On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Vencore (United States)

InstitutionResearch output, impact & collaborations

Vencore (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Vencore (United States)?

ScholarIQrecord summary

Vencore (United States) is a research organisation in Chantilly, US. OpenAlex records 1,008 works and 19,318 citations for it. 424 researchers list it as their most recent affiliation.

How many works does Vencore (United States) have?

ScholarIQindexed works

Vencore (United States) has 1,008 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Vencore (United States) have?

ScholarIQcitation count

Vencore (United States) has 19,318 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Vencore (United States)?

ScholarIQresearcher count

Vencore (United States) has 424 researchers in the ScholarIQ index.

What is the average h-index at Vencore (United States)?

ScholarIQavg h-index

Vencore (United States) has an average h-index of 53.5 in OpenAlex.

What is the ROR of Vencore (United States)?

ScholarIQror

The ROR for Vencore (United States) is on the source record.

What is the OpenAlex record for Vencore (United States)?

ScholarIQopenalex

The OpenAlex for Vencore (United States) is on the source record.

What is the Wikidata of Vencore (United States)?

ScholarIQwikidata

The Wikidata for Vencore (United States) is on the source record.

Who are the most-cited researchers behind Vencore (United States)?

ScholarIQtop researchers by citations
1
William L. Marshall · Psychopathy, Forensic Psychiatry, Sexual Offending
452 works24,553 citations
2
Eileen Farrelly · Multiple Myeloma Research and Treatments
91 works934 citations

What are the most-cited papers on Vencore (United States)?

ScholarIQmost cited works
Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma
Ajai Chari, Dorothy Romanus, Antonio Palumbo, Marlo Blazer, Eileen Farrelly, Aditya Raju, Hui Huang, Paul G. Richardson
Clinical Lymphoma Myeloma & Leukemia. 2019108 CitationsOPEN ACCESS
Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis
Christoph U. Correll, Daisy Ng‐Mak, Dana Stafkey-Mailey, Eileen Farrelly, Krithika Rajagopalan, Antony Loebel
Annals of General Psychiatry. 201779 CitationsOPEN ACCESS
Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States
Parameswaran Hari, Dorothy Romanus, Antonio Palumbo, Katarina Luptakova, Robert M. Rifkin, Linh Mai Tran, Aditya Raju, Eileen Farrelly, Stephen J. Noga, Marlo Blazer, Ajai Chari
Clinical Lymphoma Myeloma & Leukemia. 201843 CitationsOPEN ACCESS
Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd
Ajai Chari, Paul G. Richardson, Dorothy Romanus, Meletios Α. Dimopoulos, Pieter Sonneveld, Evangelos Terpos, Roman Hájek, Aditya Raju, Antonio Palumbo, Lauren E. Cain, Marlo Blazer, Hui Huang, Eileen Farrelly, Sikander Ailawadhi
Expert Review of Hematology. 202043 CitationsOPEN ACCESS
The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims
Cindy Garris, Manan Shah, Eileen Farrelly
Cost Effectiveness and Resource Allocation. 201542 CitationsOPEN ACCESS

How much of the research on Vencore (United States) is open access?

ScholarIQopen access share
91%OPEN ACCESS
Gold
18%
Green
9%
Hybrid
45%
Bronze
18%
Closed
9%

Related on ScholarIQ

470M+ articles · 14-day free trial